Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meds Apotek AB (publ)FRA:24R -1.66%12 Forward PE Ratio is 17.58 as of Aug. 14, 2026. GuruFocus rates FRA:24R with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 508 Retail - Cyclical companies, Meds Apotek AB (publ) ranks worse than 68.9% on this metric.
Meds Apotek AB (publ) (FRA:24R) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Meds Apotek AB (publ) Forward PE Ratio Related Terms
Meds Apotek AB (publ) Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Meds Apotek AB (publ)'s Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) Forward PE Ratio Chart
Meds Apotek AB (publ) Annual Data
Trend
2025-12
Forward PE Ratio
23.24
Meds Apotek AB (publ) Quarterly Data
2025-12
2026-03
2026-06
Forward PE Ratio
23.24
14.46
11.14
FRA:24R vs AMZN, BABA, PDD: Forward PE Ratio Comparison
For the Internet Retail subindustry, Meds Apotek AB (publ)'s Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) Forward PE Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s Forward PE Ratio falls into.
Meds Apotek AB (publ) Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Meds Apotek AB (publ) (FRA:24R) has a Forward PE Ratio of 17.58 as of Aug. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Meds Apotek AB (publ) and its competitors. According to the industry distribution chart, Meds Apotek AB (publ) ranks #350 out of 508 companies in the Retail - Cyclical industry, placing it in the top 68.9%.
Is Meds Apotek AB (publ)'s Forward PE Ratio too high?
Meds Apotek AB (publ)'s current Forward PE Ratio is 17.58. The Retail - Cyclical industry median Forward PE Ratio is 15.37. Meds Apotek AB (publ)'s value of 17.58 is 14.4% above this industry median. Based on the distribution chart, Meds Apotek AB (publ) ranks #350 out of 508 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Meds Apotek AB (publ) has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Forward PE Ratio compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, Meds Apotek AB (publ) ranks #350 out of 508 companies for Forward PE Ratio. This places Meds Apotek AB (publ) in the lower half of its industry. The industry median Forward PE Ratio is 15.37. Meds Apotek AB (publ)'s value of 17.58 is 14.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Retail - Cyclical company?
The median Forward PE Ratio among Retail - Cyclical companies is 15.37, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current Forward PE Ratio of 17.58 is 14.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Meds Apotek AB (publ) and its competitors. For the Retail - Cyclical industry, the median Forward PE Ratio is 15.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current Forward PE Ratio is 17.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (FRA:24R) has a current Forward PE Ratio of 17.58. The current Forward PE Ratio is 17.58 and 14.4% above the Retail - Cyclical industry median of 15.37. Meds Apotek AB (publ)'s overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Meds Apotek AB (publ) (FRA:24R), the current Forward PE Ratio is 17.58 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
12GF Score
Get the complete analysis for FRA:24R
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:24R has been successfully added to your 
